science

The Bio-Pharma Industry and Society Listing Summary Please join the CSIS Global Health Policy Center on March 17, from 10:00am – 11:30am, for an exploration of how private bio-pharmaceutical firms can better support the critically important societal goals of improved affordability, access, quality,

Independent analysis suggests retrospective change to data indicating climate change progress

Globally, less than 2% of philanthropic giving goes to mitigating climate change. Of that small amount, an even smaller sliver—just 12%—goes to Asia.

Benitec Biopharma’s SWOT analysis: gene therapy stock shows clinical promise

The Bio-Pharma Industry and Society Listing Summary Please join the CSIS Global Health Policy Center on March 17, from 10:00am – 11:30am, for an exploration of how private bio-pharmaceutical firms can better support the critically important societal goals of improved affordability, access, quality,

Argus Research Sees Long-Term Growth Ahead for Applied Materials (AMAT)

Crocs Core Brand Generates Plenty of Cash Flow, but HeyDude Continues to Struggle

Lam Research’s SWOT analysis: stock faces cleanroom constraints

Hong Kong is likely to attract more mainland Chinese retail brands, but unlike the previous wave, non food and beverage (F&B) retailers are the ones ramping up their presence, according to analysts. The change in profile of mainland brands coming to Hong Kong is helping the city’s landlords fill vac

BioCryst Pharmaceuticals’ SWOT analysis: stock eyes growth from pediatric expansion